Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) Q4 2024 Earnings Call Transcript March 4, 2025
Amylyx Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $-0.55 EPS, expectations were $-0.49.
Operator: Good morning. My name is Jenny, and I will be your conference operator today. At this time, I would like to welcome everyone to the Amylyx Pharmaceuticals’ Fourth Quarter and Full Year 2024 Earnings Conference Call. [Operator Instructions] Please be advised that this call is...
